Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 175, Issue 5, Pages 2043-2052Publisher
ELSEVIER SCIENCE INC
DOI: 10.2353/ajpath.2009.090015
Keywords
-
Categories
Funding
- Canadian Institutes of Health Research
- AllerGen Network of Canadian Centres of Excellence
- Alberta Heritage Foundation for Medical Research, Canada
- National Health, and Medical Research Council of Australia (NHMRC)
- Peter Doherty Fellowship
Ask authors/readers for more resources
Eosinophils expressing indoleamine 2, 3-dioxygenase (IDO) may contribute to T-helper cell (Th)2 predominance. To characterize human thymus IDO+ eosinophil ontogeny relative to Th2 regulatory gene expression, we processed surgically obtained thymi from 22 children (age: 7 days to 12 years) for immunohistochernistry and molecular analysis, and measured cytokine and kynurenine levels in tissue homogenates. Luna+ eosinophils (similar to 2% of total thymic cefls) decreased in number with age (P = 0.02) and were IDO+. Thymic IDO immunoreactivity (P = 0.01) and kynurenine concentration (P = 0.01) decreased with age as well. in addition, constitutively-expressed interleukin (IL)-5 and IL-13 in thymus supernatants was highest in youngest children. Eosinophil numbers correlated positively with expression of the Th2 cytokines IL-5, IL-13 (r = 0.44, P = 0.002), and IL-4 (r = 0.46, P = 0.005), transcription factor signal transducer and activator of transcription-6 (r = 0.68, P = 0.001), and the chemokine receptor, CCR3 (r = 0.17, P = 0.04), but negatively with 11,47 mRNA (r = -0.57, P = 0.02) and toll-like receptor 4 expression (r = -0.74, P = 0.002). Taken together, these results suggest that functional thymic IDO+ eosinophils during human infant life may have an immunomodulatory role in Th2 immune responses. (Am J Pathol 2009, 175:2043-2052; DOI: 10.2353/ajpath.2009.090015)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available